Search

Your search keyword '"Diabetes Mellitus"' showing total 9,108 results
Start Over Descriptor "Diabetes Mellitus" Publication Type News
9,108 results on '"Diabetes Mellitus"'

7. Insulin-dependence as a Predictor of Shortened Cancer-specific Survival in Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study from the United States Neuroendocrine Study Group

Subjects
Diabetes mellitus, Cancer research, Tumors, Insulin, Oncology, Experimental, Diabetes, Cancer -- Research
Abstract

2024 OCT 1 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2024

27. Supply Of Consumables For Insulin Pumps (reservoir For Insulin Pumps) To Provide Citizens With Diabetes Mellitus, Within The Framework Of The diabetes Mellitus Subprogram Of The Departmental Target

Subjects
Group purchasing organizations, Diabetes mellitus, Insulin pumps, Diabetes therapy, Reservoirs (Water), Insulin, Business, international
Abstract

Tenders are invited for Supply of consumables for insulin pumps (reservoir for insulin pumps) to provide citizens with diabetes mellitus, within the framework of the diabetes mellitus subprogram of the [...]

Published
2020

28. SFC Fluidics, Inc. Receives FDA Breakthrough Device Designation

Subjects
United States. Food and Drug Administration, Diabetes mellitus, Diabetes therapy, Microfluidics, Business, international
Abstract

(PRWeb) - SFC Fluidics, Inc. (SFC) is pleased to announce that its interoperable insulin delivery pod (the PandaTM), in late-stage development, has been granted Breakthrough Device Designation (BDD) by the [...]

Published
2020

29. SFC Fluidics, Inc. Receives FDA Breakthrough Device Designation

Subjects
United States. Food and Drug Administration, Diabetes mellitus, Diabetes therapy, Microfluidics, Business, international, Law
Abstract

(PRWeb) - SFC Fluidics, Inc. (SFC) is pleased to announce that its interoperable insulin delivery pod (the PandaTM), in late-stage development, has been granted Breakthrough Device Designation (BDD) by the [...]

Published
2020

30. SFC Fluidics, Inc. Receives FDA Breakthrough Device Designation

Subjects
United States. Food and Drug Administration, Diabetes mellitus, Diabetes therapy, Business, general
Abstract

FAYETTEVILLE, Ark. (PRWEB) December 01, 2020 SFC Fluidics, Inc. (SFC) is pleased to announce that its interoperable insulin delivery pod (the PandaTM), in late-stage development, has been granted Breakthrough Device [...]

Published
2020

32. Nigeria: Expert Decries High Rate of Diabetes in Nigeria

Subjects
Merck & Company Inc., Diabetes mellitus, Diabetes therapy, Pharmaceutical industry, Diabetics, News, opinion and commentary
Abstract

Byline: Gabriel Enogholase Benin-City -- A Nephrologist, Dr Osunbor Osariemen, has decried the increasing rate of Diabetes mellitus in Nigeria lamenting that the national prevalent rate was now 4.3 percent. [...]

Published
2020

33. Ghana: Diabetes - Novo Nordisk to Offer Free Insulin to Children in Nigeria, Ghana

Subjects
Novo Nordisk A/S, Diabetes mellitus, Pharmaceutical industry, Insulin, News, opinion and commentary
Abstract

Byline: Agency Report According to Mr Abonu, the free supply of insulin to children project, tagged 'Changing Diabetes in Children', will start in 2021 in Ghana and Nigeria, in fulfillment [...]

Published
2020

34. 69.9 million Indians to be diabetic by 2025, 80 million by 2030

Subjects
Diabetes mellitus, Developing countries, Biotechnology industry
Abstract

The diabetic population in the country is close to hitting the alarming mark of 69.9 million by 2025 and 80 million by 2030. This denotes that the developing country is [...]

Published
2020

36. Testing Of Digital Supply Offers For Self-management Of Diabetes Mellitus

Subjects
Self care (Health), Diabetes mellitus, Diabetes therapy, Business, international
Abstract

Contract notice: Testing of digital supply offers for self-management of diabetes mellitus The contractual partner will treat patients with the disease diabetes mellitus (ICD-10-GM-2019-Code E10-E14), for whom the use of [...]

Published
2020

38. Fix Impotence With The Best Amazing Medication: Cenforce 150 mg

Subjects
Impotence, Diabetes mellitus, Vascular diseases, General interest
Abstract

India, June 19 -- Erectile Disorder Categories and Underlying Causes 1. Arteriogenic (insufficient arterial blood supply): Possible causes include atherosclerosis, HTN, hyperlipidemia, smoking, pelvic trauma, and also diabetes mellitus. 2. [...]

Published
2020

39. Resverlogix Announces Key BETonMACE Renal Data from Plenary Session Presentation at ERA-EDTA Virtual Congress

Subjects
Coronary heart disease -- Political aspects, Type 2 diabetes -- Political aspects, Organ transplantation -- Political aspects, Cardiac patients -- Political activity -- Political aspects, EDTA -- Political aspects, Chronic kidney failure -- Political aspects, Hypertension, Surgery, Diabetes mellitus, Clinical trials, Kidney transplantation, Diseases, Kidney diseases, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - Resverlogix Corp. ('Resverlogix') (TSX:RVX) is pleased to announce key data from its BETonMACE clinical trial in pre-specified stage 3 chronic kidney disease (CKD) patients. This data was presented [...]

Published
2020

40. Resverlogix Announces Key BETonMACE Renal Data from Plenary Session Presentation at ERA-EDTA Virtual Congress

Subjects
Coronary heart disease -- Political aspects, Type 2 diabetes -- Political aspects, Organ transplantation -- Political aspects, Cardiac patients -- Political activity -- Political aspects, EDTA -- Political aspects, Chronic kidney failure -- Political aspects, Hypertension, Surgery, Diabetes mellitus, Clinical trials, Kidney transplantation, Diseases, Kidney diseases, Business, international, Law
Abstract

(GlobeNewswire) - Resverlogix Corp. ('Resverlogix') (TSX:RVX) is pleased to announce key data from its BETonMACE clinical trial in pre-specified stage 3 chronic kidney disease (CKD) patients. This data was presented [...]

Published
2020

41. Resverlogix Announces Key BETonMACE Renal Data from Plenary Session Presentation at ERA-EDTA Virtual Congress

Subjects
Coronary heart disease -- Political aspects, Type 2 diabetes -- Political aspects, Organ transplantation -- Political aspects, Cardiac patients -- Political activity -- Political aspects, EDTA -- Political aspects, Chronic kidney failure -- Political aspects, Hypertension, Surgery, Diabetes mellitus, Clinical trials, Kidney transplantation, Diseases, Kidney diseases, Banking, finance and accounting industries, Business
Abstract

CALGARY, Alberta, Jun 09, 2020 (GLOBE NEWSWIRE via COMTEX) -- Resverlogix Corp. ('Resverlogix') (TSX:RVX) is pleased to announce key data from its BETonMACE clinical trial in pre-specified stage 3 chronic [...]

Published
2020

42. Ghana: Confirmed COVID-19 Cases Tally Up 9,462 ... 3,547 Recoveries, 44 Deaths

Subjects
Coronaviruses, Diabetes mellitus, Health, Stroke, Women, Asthma, News, opinion and commentary
Abstract

Byline: Abigail Annoh Ghana's coronavirus (COVID-19) cases now stands at 9,462, latest updates from the Ghana Health Service (GHS) have confirmed. The cases are up by 294 from its last [...]

Published
2020

43. Marksans Pharma gains on recalling one batch of Metformin Extended Release Tablets

Subjects
Metformin -- Product defects and recalls, Type 2 diabetes, Diabetes therapy -- Product defects and recalls, Blood glucose, Diabetes mellitus, Glucose, Hypoglycemic agents, Business, international
Abstract

Metformin Extended Release Tablets USP 500 mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus Marksans Pharma [...]

Published
2020

44. Marksans Pharma recalls one batch of Metformin Extended Release Tablets

Subjects
Metformin -- Product defects and recalls, Type 2 diabetes, Diabetes therapy -- Product defects and recalls, Blood glucose, Diabetes mellitus, Glucose, Hypoglycemic agents, Business, international
Abstract

Metformin Extended Release Tablets USP 500 mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus Marksans Pharma [...]

Published
2020

45. More Diabetes Medication Recalled Over Cancer Fears

Subjects
Cancer -- Drug therapy, Metformin -- Product defects and recalls, Type 2 diabetes -- Drug therapy, Diabetes therapy -- Product defects and recalls, Blood glucose, Prescriptions (Drugs) -- Product defects and recalls, Drugs, Diabetes mellitus, Glucose, Hypoglycemic agents, Business, international, News, opinion and commentary
Abstract

Following two other recalls from (https://www.ibtimes.com/diabetes-drug-recall-2020-metformin-recalled-over-cancer-risk-2984955?utm_source=feeds_ibt&utm_medium=feed&utm_campaign=_content) Apotox Corp. and (https://www.ibtimes.com/diabetes-drug-recall-2020-another-metformin-medication-recalled-over-cancer-concerns-2986608?utm_source=feeds_ibt&utm_medium=feed&utm_campaign=_content) Amneal Pharmaceuticals for the diabetes drug Metformin because of higher than acceptable levels of Nitrosodimethylamine (NDMA), a cancer-causing ingredient, (https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-pharmaceuticals-usa-inc-initiates-voluntary-nationwide-recall-metformin-hydrochloride-extended) [...]

Published
2020

46. More Diabetes Medication Recalled Over Cancer Fears

Subjects
Cancer -- Drug therapy, Metformin -- Product defects and recalls, Type 2 diabetes -- Drug therapy, Diabetes therapy -- Product defects and recalls, Blood glucose, Prescriptions (Drugs) -- Product defects and recalls, Drugs, Diabetes mellitus, Glucose, Hypoglycemic agents, Business, international, News, opinion and commentary
Abstract

Following two other recalls from (https://www.ibtimes.com/diabetes-drug-recall-2020-metformin-recalled-over-cancer-risk-2984955?utm_source=feeds_ibt&utm_medium=feed&utm_campaign=_content) Apotox Corp. and (https://www.ibtimes.com/diabetes-drug-recall-2020-another-metformin-medication-recalled-over-cancer-concerns-2986608?utm_source=feeds_ibt&utm_medium=feed&utm_campaign=_content) Amneal Pharmaceuticals for the diabetes drug Metformin because of higher than acceptable levels of Nitrosodimethylamine (NDMA), a cancer-causing ingredient, (https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-pharmaceuticals-usa-inc-initiates-voluntary-nationwide-recall-metformin-hydrochloride-extended) [...]

Published
2020

48. European Steering Committee launch 'A New Era in Diabetes Care' report highlighting the need to improve the quality of care for people with type 2 diabetes and renal|cardiovascular complications

Subjects
Type 2 diabetes -- Complications and side effects, Patient care -- Reports, Diabetes therapy -- Reports, Medical care quality -- Reports, Diabetes mellitus, Europeans, Diseases, General interest, News, opinion and commentary
Abstract

CAMBRIDGE: Mundipharma has issued the following press release: A new expert-led report has today been launched to help outline key challenges and inequalities in the care of type 2 diabetes [...]

Published
2020

49. A Non-Precedential Case Study: Federal Circuit Says District Court Did Not Clearly Err In Holding Dosing Patent Invalid Based On Obviousness And Obviousness Type Double Patenting

Subjects
Type 2 diabetes -- Cases -- Case studies, Diabetes therapy -- Cases -- Case studies -- Intellectual property, Patent infringement -- Cases -- Case studies, Diabetes mellitus, Linagliptin, Patent law, Company legal issue, Business, international
Abstract

Holding: In Boehringer Ingelheim Pharms. Inc. v. Mylan Pharms. Inc., No. 2019-1172 (Fed. Cir. March 16, 2020) (non-precedential), the Federal Circuit upheld the district court's finding of invalidity of certain [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results